Doporio 25 mg/250 mg tablete
| Name | Doporio 25 mg/250 mg tablete |
|---|---|
| Marketing Authorisation Number | HR-H-150425788 |
| Active Substance | karbidopa hidrat levodopa |
| Composition | Jedna tableta sadrži 25 mg karbidope u obliku karbidope hidrata i 250 mg levodope |
| Pharmaceutical Form | Tableta |
| Manufacturer | Orion Corporation, Salo, Southwest Finland, Finska |
| Marketing Authorisation Holder | Orion Corporation, Orionintie 1, Espoo, Finska |
| Marketing Authorisation Date | 25.04.2024 |
| MA Period of Validity | 25.04.2029 |
| Classification Number | UP/I-530-09/23-01/41 |
| Registration Number | 381-12-01/286-24-08 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | N04BA02 |
| Marketing status | Never marketed |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
